<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="6370">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01673503</url>
  </required_header>
  <id_info>
    <org_study_id>S-20100111</org_study_id>
    <nct_id>NCT01673503</nct_id>
  </id_info>
  <brief_title>A Prospective Study of Femtosecond Laser Intracorneal Lensectomi</brief_title>
  <official_title>A Prospective Study of Femtosecond Laser Intracorneal Lensectomi in Treatment of Moderate to High Myopia</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Odense University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Aarhus University Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Odense University Hospital</source>
  <oversight_info>
    <authority>Denmark: University of Southern Denmark</authority>
    <authority>Denmark: Department of Ophthalmology at both Odense University Hospital and Aarhus University Hospital - Aarhus Sygehus.</authority>
    <authority>Denmark: The Regional Scientific Ethical Committee for Southern Denmark</authority>
    <authority>Denmark: The Central Denmark Region Committees on Health Research Ethics</authority>
    <authority>Denmark: The Danish Data Protection Agency</authority>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to compare visual acuity, safety, predictability, corneal
      biomechanics, dry eyes, and nerve-morphology after all femtosecond laser refractive
      lenticule extraction. Approximately 30 to 40 patients with moderate to high myopia will
      randomly (after ocular dominance) receive ReLEx flex in one eye, and ReLEx smile in the
      other.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>May 2011</start_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Single Blind (Subject), Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>Visual acuity</measure>
    <time_frame>up to  6 months</time_frame>
    <safety_issue>Yes</safety_issue>
    <description>Using ETDRS charts, both uncorrected and corrected distance visual acuity, along with visual acuity using the FrACT contrast chart</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>refractive predictability</measure>
    <time_frame>Pre-surgery, 1 week, 1 month, 3 months, 6 months</time_frame>
    <safety_issue>Yes</safety_issue>
    <description>Optometrists measure refraction at follow-up-examinations, and the refraction 6 monhts after surgery will be compared to the target refraction to calculate refractive predictability</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Corneal biomechanics, corneal nerve changes and dry eye symptoms</measure>
    <time_frame>pre-surgery and 6 months after</time_frame>
    <safety_issue>Yes</safety_issue>
    <description>Corneal hysteresis and corneal resistence factor using the Ocular response analyser, nerve changes using the Cochet-Bonnet Aesthesiometer and confokal mikroscopy, and dry eyes symptoms using Schirmers test, Tear BUT, and Oculus keratograph, along with anterior segment OCT to measure tear meniscus hight.</description>
  </other_outcome>
  <enrollment>35</enrollment>
  <condition>Myopia</condition>
  <condition>Astigmatism</condition>
  <arm_group>
    <arm_group_label>Carl Zeiss Meditech VisuMax laser - ReLEx flex</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>&gt;30 patients will receive treatment for myopia with a VisuMax femtosecond laser from Carl Zeiss. The laser can cut with two different settings, called ReLEx flex and ReLEx smile. One eye will recieve ReLEx flex, and the other ReLEx smile</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Carl Zeiss Meditech VisuMax laser - ReLEx smile</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>&gt;30 patients will receive treatment for myopia with a VisuMax femtosecond laser from Carl Zeiss. The laser can cut with two different settings, called ReLEx flex and ReLEx smile. One eye will recieve ReLEx flex, and the other ReLEx smile</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Carl Zeiss Meditech VisuMax laser</intervention_name>
    <description>Refractive lenticule extraction (ReLEx) with the Carl Zeiss Meditech VisuMax laser</description>
    <arm_group_label>Carl Zeiss Meditech VisuMax laser - ReLEx flex</arm_group_label>
    <arm_group_label>Carl Zeiss Meditech VisuMax laser - ReLEx smile</arm_group_label>
    <other_name>Refractive lenticule extraction, ReLEx</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  25 to 45 years,

          -  moderate to high myopia with astigmatism =&lt; 2 D,

          -  otherwise eye healthy,

          -  CDVA of 0.8 or better (Snellen).

        Exclusion Criteria:

          -  systemic or ocular disease or previous eye surgery,

          -  thin cornea,

          -  a difference of more than 2 D myopia in the eyes of each subject.
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>25 Years</minimum_age>
    <maximum_age>45 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Anders H Vestergaard, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Odense University Hospital, University of Southern Denmark</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Department of Ophthalmology Aarhus Sygehus - Aarhus University Hospital, Denmark</name>
      <address>
        <city>Aarhus</city>
        <zip>8000</zip>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Denmark</country>
  </location_countries>
  <verification_date>January 2013</verification_date>
  <lastchanged_date>January 23, 2013</lastchanged_date>
  <firstreceived_date>August 20, 2012</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Southern Denmark</investigator_affiliation>
    <investigator_full_name>Anders H. Vestergaard</investigator_full_name>
    <investigator_title>MD, PhD student</investigator_title>
  </responsible_party>
  <keyword>Myopia</keyword>
  <keyword>refractive surgery</keyword>
  <keyword>all femtosecond laser</keyword>
  <keyword>ReLEx flex</keyword>
  <keyword>ReLEx smile</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Astigmatism</mesh_term>
    <mesh_term>Myopia</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
